Cognition Therapeutics, Inc. Share Price
NASDAQ: CGTX | Micro CapCognition Therapeutics, Inc. Stock Performance
Open $1.09 | Prev. Close $1.13 | Circuit Range N/A |
Day Range $1.07 - $1.12 | Year Range $0.55 - $3.83 | Volume 23,376 |
Average Traded $1.09 |
Cognition Therapeutics, Inc. Share Price Today
As of 10 August 2026, Cognition Therapeutics, Inc.'s share price is $1.07. The stock opened at $1.09, compared to its previous close of $1.13. During today's trading session, Cognition Therapeutics, Inc.'s share price traded between $1.07 and $1.12, with an average price of $1.10. Over the past 52 weeks, the stock has recorded a high of $3.83 and a low of $0.55. In terms of performance, Cognition Therapeutics, Inc.'s share price has declined by 0.92% over the last six months and is down 55.67% on a year-on-year basis.
Cognition Therapeutics, Inc. Share Price Chart
Cognition Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $78.22M | PE Ratio (TTM) -3.36 | Dividend Yield N/A |
EPS (TTM) $-0.32 | Revenue (TTM) N/A | Return On Equity (TTM) -68.53% |
Profit Margin N/A | Debt to Equity 0.41 | Quarterly Earnings Growth YoY 50.39% |
Cognition Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Cognition Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. Cognition Therapeutics, Inc. was incorporated in 2007 and is based in Purchase, New York.
Cognition Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $0.90 | $1.07 | +20.65% |
Jul 2026 | $1.19 | $0.89 | -22.52% |
Jun 2026 | $1.17 | $1.15 | -3.36% |
May 2026 | $1.26 | $1.19 | -5.93% |
Apr 2026 | $0.83 | $1.26 | +67.11% |
Mar 2026 | $1.07 | $0.76 | -30.23% |
Feb 2026 | $1.13 | $1.08 | +0.46% |
Jan 2026 | $1.40 | $1.08 | -19.40% |
Dec 2025 | $1.74 | $1.34 | -22.32% |
Nov 2025 | $1.76 | $1.73 | -3.90% |
Oct 2025 | $1.39 | $1.79 | +32.47% |
Sep 2025 | $2.43 | $1.35 | -44.12% |
CGTX Share Price FAQs
What is Cognition Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Cognition Therapeutics, Inc. stock?
What is CGTX's market capitalisation today?
What is CGTX's net income for the last quarter?
What is the 5 year returns of CGTX?
What is the high & low stock price of CGTX today?
Can I buy CGTX shares in India?